Literature DB >> 21498621

Hyperosmolar stress upregulates HLA-DR expression in human conjunctival epithelium in dry eye patients and in vitro models.

Piera Versura1, Vincenzo Profazio, Costantino Schiavi, Emilio C Campos.   

Abstract

PURPOSE: To investigate the immune response of human conjunctival epithelium to hyperosmolar stress.
METHODS: Tear osmolarity was measured in 15 normal subjects and 25 dry eye (DE) patients; conjunctival imprint cytology samples were obtained at the nasal bulbar area. Subconfluent primary human conjunctival epithelial cells (pHCECs) and human conjunctival organ cultures (hCOCs), both cultured in iso-osmolar medium (305 mOsm/L), were exposed for 24 hours to media with progressively higher osmolarity, with or without the ion channel inhibitor ruthenium red (RuR). Human leukocyte antigen (HLA)-DR expression was evaluated by immunocytochemistry, on imprints from subjects, on primary human conjunctival epithelial cells, on formalin fixed-paraffin embedded hCOCs, and by RT-PCR. Statistical evaluation was performed by applying the unpaired Student's t test, as well as Spearman's rho and Pearson's r correlation coefficients (significance P < 0.05).
RESULTS: HLA-DR expression increased in DE subjects with respect to control (% mean ± SD, respectively, 46.16 ± 7.2 vs. 7.48 ± 1.14, P < 0.0001) and exhibited significantly high correlations with tear osmolarity values (r = 0.614; P < 0.0001). In vitro experiments showed a progressive increase in HLA-DR expression as the osmolarity of the medium was increased from 6.75 ± 1.16 (% mean ± SD) in iso-osmolar-cultured cells to 9.96 ± 1.37 and 12.94 ± 4.04 in cells cultured in, respectively, 350 and 400 mOsm/L (P < 0.05). A stepwise progressive increase was also found in hCOCs. Results were confirmed by RT-PCR. Ruthenium red significantly reduced HLA-DR expression in hyperosmolar-cultured cells.
CONCLUSIONS: Data from complementary techniques demonstrate that extracellular hyperosmolarity induces HLA-DR overexpression in human conjunctival epithelial cells in both DE patients and in vitro cell culture models.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21498621     DOI: 10.1167/iovs.11-7215

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  A model for tear film thinning with osmolarity and fluorescein.

Authors:  Richard J Braun; Nicholas R Gewecke; Carolyn G Begley; P Ewen King-Smith; Javed I Siddique
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-26       Impact factor: 4.799

2.  Assessment of corneal epithelial thickness in dry eye patients.

Authors:  Xinhan Cui; Jiaxu Hong; Fei Wang; Sophie X Deng; Yujing Yang; Xiaoyu Zhu; Dan Wu; Yujin Zhao; Jianjiang Xu
Journal:  Optom Vis Sci       Date:  2014-12       Impact factor: 1.973

3.  Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress.

Authors:  Xia Hua; Zhitao Su; Ruzhi Deng; Jing Lin; De-Quan Li; Stephen C Pflugfelder
Journal:  Curr Eye Res       Date:  2014-10-01       Impact factor: 2.424

4.  HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease.

Authors:  Seth P Epstein; Neha Gadaria-Rathod; Yi Wei; Maureen G Maguire; Penny A Asbell
Journal:  Exp Eye Res       Date:  2013-04-06       Impact factor: 3.467

Review 5.  The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Ophthalmology       Date:  2017-11       Impact factor: 12.079

6.  Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro.

Authors:  Chloé Clouzeau; David Godefroy; Luisa Riancho; William Rostène; Christophe Baudouin; Françoise Brignole-Baudouin
Journal:  Mol Vis       Date:  2012-04-06       Impact factor: 2.367

7.  Conjunctival HLA-DR and CD8 expression detected by impression cytology in ocular graft versus host disease.

Authors:  Philipp Eberwein; Susanne Issleib; Daniel Böhringer; Hans Mittelviefhaus; Johannes Schwartzkopff; Juergen Finke; Thomas Reinhard
Journal:  Mol Vis       Date:  2013-07-19       Impact factor: 2.367

Review 8.  Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.

Authors:  Terry G Coursey; Cintia S de Paiva
Journal:  Clin Ophthalmol       Date:  2014-08-04

9.  Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution.

Authors:  Karen B Fernandez; Seth P Epstein; Geoffrey S Raynor; Alan T Sheyman; Morgan L Massingale; Peter G Dentone; Lukas D Landegger; Penny A Asbell
Journal:  Clin Ophthalmol       Date:  2015-06-24

10.  Quantitative analysis of tear film fluorescence and discomfort during tear film instability and thinning.

Authors:  Carolyn Begley; Trefford Simpson; Haixia Liu; Eliza Salvo; Ziwei Wu; Arthur Bradley; Ping Situ
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-12       Impact factor: 4.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.